Dmitrybrings 10 years experience American innovative Pharmaceutical companies in theregion of Central Asia. In recent years, Dmitry has been an active participant in Intellectual Property Rights protection which is of utmost importance forinnovative pharma as Investment climate of Kazakhstan. While at Pfizer, Dmitryhad the privilege to help Kazakhstan and other countries in Central Asia getaccess to COVID-19 vaccine and roll-out vaccination plans. He is currently implementing one of the largest pharma contract manufacturing projects in KZ entering the investor playing field.